2022 annual financial data
ANI Pharmaceuticals 2022 Operating margin
Direct answer
Operating margin was -11.15%.
Operating income was -35,283,000 USD and net income was -47,896,000 USD.
Operating cash flow was -31,203,000 USD.
Get free ANI Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 316,385,000 USD
- Operating income
- -35,283,000 USD
- Net income
- -47,896,000 USD
- Operating cash flow
- -31,203,000 USD